Michigan State University is a public land-grant research university in East Lansing, Michigan. MSU was founded in 1855 and served as a model for land-grant colleges and universities later created under the Morrill Act of 1862.

During the past decade, Michigan State University conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 36 clinical trials were completed, i.e. on average, 49.3% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 17 clinical trials were completed. i.e. 56.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michigan State University" #1 sponsor was "Michigan State University" with 29 trials, followed by "Children's Oncology Group" with 9 trials sponsored, "NSABP Foundation Inc" with 9 trials sponsored, "BrainScope Company, Inc." with 6 trials sponsored and "Baxalta now part of Shire" with 6 trials sponsored. Other sponsors include 91 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan State University" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Michael J. Fox Foundation for Parkinson's Research" with 7 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 7 trials as a collaborator, "Pfizer" with 5 trials as a collaborator and "Big Ten Cancer Research Consortium" with 4 trials as a collaborator. Other collaborators include 101 different institutions and companies that were collaborators in the rest 79 trials.

According to Clinical.Site data, the most researched conditions in "Michigan State University" are "Breast Cancer" (10 trials), "Parkinson Disease" (8 trials), "Alzheimer's Disease" (7 trials), "Concussion, Brain" (6 trials) and "Concussion, Intermediate" (6 trials). Many other conditions were trialed in "Michigan State University" in a lesser frequency.

Most popular intervention types in "Michigan State University" are "Drug" (88 trials), "Behavioral" (25 trials), "Device" (14 trials), "Other" (14 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "cyclophosphamide" (8 trials), "placebo" (6 trials), "filgrastim" (4 trials) and "Bapineuzumab 0.5 mg/kg" (3 trials). Other intervention names were less common.

The vast majority of trials in "Michigan State University" are 127 trials for "All" genders, 23 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Michigan State University". 2 are not yet recruiting, 15 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 104 completed trials in Michigan State University, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Michigan State University, 11 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 36 trials that are defined as “Not Applicable".

Michigan State University has several departments that took part in Clinical trials: "Breslin Cancer Center at Ingham Regional Medical Center" - 95 trials, "Michigan State University Department of Neurology" - 7 trials, "Michigan State University Center for Bleeding and Clotting Disorders" - 6 trials, "Michigan State Univ., Infectious Disease Clinic CRS" - 3 trials, "MSU Musculoskeletal Rehabilitation" - 3 trials, "Michigan State University Center for Orthopedic Research" - 3 trials, "Department of Kinesiology" - 2 trials